Evaluation of an Erysipelothrix rhusiopathiae experimental infection In pigs vaccinated with ERYSENG®

Home Knowledge Evaluation of an Erysipelothrix rhusiopathiae experimental infection In pigs vaccinated with ERYSENG®

Evaluation of an Erysipelothrix rhusiopathiae experimental infection In pigs vaccinated with ERYSENG®

The aim of this study was to demonstrate the efficacy of ERYSENG® in pigs against swine erysipelas after a challenge with two different E. rhusiopathiae virulent strains, corresponding to serotype 1 and serotype 2.

About this article

Appeared in

ESPHM Congress, 2015

Authors

Simon-Grifé, M.; Guàrdia, M.; Roca, M.; Camprodon, A.; Pedrazuela, R.; Fontseca, M.; March, R.

Summary

ERYSENG® administered by intramuscular route in pigs prevents the body temperature increase and the clinical signs produced by an experimental infection with two different E. rhusiopathiae virulent strains corresponding to serotype 1 and serotype 2.

Related services

Related products

Share this on